132 research outputs found
Book review: Men’s cinema: masculinity and mise-en-scène in Hollywood, by Stella Bruzzi
No full textBook review of: Men’s cinema: masculinity and mise-en-scène in Hollywood, by Stella Bruzzi. Edinburgh: Edinburgh University Press, 2013; ISBN 9780748676163 (£19.99)Publisher PD
L’ipercolesterolemia familiare: terapia farmacologica
No full textNei casi di dislipidemia d’origine genetica, spesso associati a gravi quadri di morbilità e mortalità cardio-vascolari già in giovane età, la diagnosi e il trattamento precoci risultano cruciali per prevenire o ritardare le complicanze. a dieta, povera di grassi saturi e di colesterolo, deve essere considerata il primo approccio terapeutico nei bambini di età superiore ai 2 anni con ipercolesterolemia ; essa garantisce infatti il mantenimento di un apporto nutrizionale adeguato alla crescita e al regolare sviluppo puberale. Si consiglia di limitare l’uso dei farmaci ipocolesterolemizzanti ai pazienti di età superiore ai 10 anni in cui la dieta, seppur severa, non sia efficace, soprattutto se sono presenti più fattori di rischio cardiovascolari. Ad oggi, tra tutti i farmaci ipocolesterolemizzanti, solo le resine sequestranti acidi biliari sono raccomandate nell’infanzia e nell’adolescenza. La loro scarsa palatibilità limita la compliance alla terapia in età pediatrica. Sempre maggiore è l’interesse verso le statine. Gli studi presenti in letteratura sull’efficacia e la sicurezza delle statine in pediatria danno risultati positivi, seppur condotti su casistiche limitate e prendendo in esame solo gli effetti avversi a breve termine. Recentemente un nuovo farmaco, ezetimibe, sembra efficace e sinergico all’attività terapeutica delle statine. Questa revisione si propone di segnalare le più recenti acquisizioni sulla diagnosi, la terapia e il follow-up dell’ipercolesterolemia familiare in età pediatrica
Obesity in adolescence: Its prevention and psycho-social aspects [Prevenzione e aspetti psico-sociali dell'obesità in età evolutiva]
No full textObesity is the most frequent nutritional disorder in adolescence and the rapid rise in its prevalence is one of the most alarming public health issue that western countries have to face nowadays. Directly associated with the rise in adolescence obesity is an increase in the prevalence of weight-related medical problems such as type 2 diabetes and metabolic syndrome. Therefore, obese adolescents might even be the first generation to die before their parents. Interventions that target risk factors for obesity at the individual, family and community levels are needed in order to prevent its increasing prevalence. Being adolescence not only one of the most vulnerable periods for the development of obesity but also the most important formative period in life, youth is a priority population for intervention strategies on both food behaviour and physical activity
Evaluation of Cardiovascular Risk in Childhood: Data from a Survey of Dyslipidaemic Children
No full textDyslipidaemia is a well-known risk factor in developing cardiovascular disease (CVD) already in childhood
The Risk of Metabolic Syndrome among Dyslipidemic Children and Adolescents
No full textIn our outpatient setting of dyslipidemic children, the finding of high TG and low HDL levels helps in discriminating patients with MetS, especially when associated with increased BMI-SDS, insulin resistance and high SBP. Our data highlight the presence of a cluster of conditions that concurrently increased the cardiovascular risk already in childhood and, therefore, that had to be globally investigated
Energy and the European Economic Union: Hints from Renewables
No full textThe paper addresses the extreme weakness of the European Union in the energy sector, which is at the core of the current economic crisis. After highlighting the multi-level framework in which decisions are made, the paper focuses on the experience gained over the past twenty years in the renewable energy sector. Specifically, the author highlights that the European Union acted as an innovator and first mover, to be surpassed by China due to the EU’s inability to handle the scaling up of the technology. The paper proposes placing industrial policy for energy at the heart of the relaunch of the still uncompleted Economic Union project
When sarcoidosis hits down: a case of prostatic sarcoidosis.
No full textA 69-year-old North African male with established diagnosis of sarcoidosis underwent a stereotactic prostate biopsy with fusion technique. At the histological analysis, non-necrotizing microgranulomas were highlighted in 2 samples, while the immunohistochemical staining resulted negative for CK903/p63/racemase. To the best of our knowledge, only 16 cases of prostatic sarcoidosis have been reported in literature. With this case report we describe an incidental diagnosis of prostatic involvement of sarcoidotic disease and briefly review and discuss the available literature on the topic
- …
